Relugolix and Lumefantrine: Interaction Details
- Relugolix
- Orgovyx
Medically reviewed by Dr. Brian Staiger, PharmD, BCPS
Also reviewed by the HelloPharmacist Editorial Team Updated AI-assisted Details about this page
- Dr. Brian Staiger, PharmD, BCPS, is a clinical pharmacist and pharmacotherapy specialist.
- AI-assisted, written
- AI is used only to summarize verified clinical information, never the open internet.
- Editorial policy
- How we build our interaction pages →
- Our AI policy →
A close look at the Relugolix and Lumefantrine interaction:
Lumefantrine
We don't have a separate drug information page for Lumefantrine. The FDA's drug directory lists it as part of Coartem (artemether and lumefantrine). Read the Artemether and Lumefantrine drug information page → Have a question about Lumefantrine? Ask a pharmacist, free →
What Happens When You Take Relugolix With Lumefantrine
What can happen when they are taken together (rated Major)
Reduced artemether/lumefantrine exposure, reduced of artemether/lumefantrine, loss of antimalarial efficacy and an increased risk of
Interaction Deep Dive
A note from Dr. Brian Staiger If you’re a patient, this deep dive may be too technical, or bore you (or both). Read the plain-language explanation →
Use caution when combining artemether/lumefantrine with relugolix, which is a , because this combination can lower exposure to artemether/lumefantrine and thereby diminish its efficacy.2 Because artemether/lumefantrine prolongs the , giving relugolix alongside it may produce QT interval effects.
In patients who have congenital long QT syndrome, congestive heart failure, or recurrent electrolyte disturbances, as well as those receiving other agents known to prolong the QT interval, weigh whether the benefits of androgen deprivation therapy such as relugolix justify the potential risks. Any electrolyte abnormalities should be corrected, and periodic and electrolyte monitoring should be considered.1
The Relugolix and Lumefantrine Interaction, Explained
You've been prescribed relugolix (Orgovyx) for prostate cancer, and you may also take artemether/lumefantrine to treat or prevent malaria. There are two things worth knowing. First, relugolix can speed up how your body breaks down the malaria medicine, which could make it work less well against the infection. Second, both medicines can affect your heart's rhythm (the ), and together that effect can add up.
This is based on how the drugs are expected to behave, not on confirmed cases, so please don't panic. Keep taking both exactly as prescribed and let your care team know you're on both. They can watch you closely and manage this safely.
Direction: Relugolix is a and may increase of artemether/lumefantrine, lowering their systemic exposure and risking reduced antimalarial . Neither is activated by this pathway here, so reduces effect.
risk: Both agents prolong the ; may be additive.
- Evidence: theoretical; onset unspecified; severity major.
- Management: Weigh benefit of ADT in patients with congenital long QT, CHF, electrolyte abnormalities, or other QT-prolonging drugs. Correct electrolytes; consider periodic and electrolyte monitoring. Watch for malaria treatment failure.
See the 2 references behind this explanation ↓
From the HelloPharmacist Pharmacy Team
AI-assisted: written with AI from this pair’s record in our interaction database, and reviewed by the HelloPharmacist pharmacy team. Written .
How we build these pages · How we use AI · Our editorial policy
Why Relugolix and Lumefantrine Interact
The likely mechanism
of -mediated of artemether/lumefantrine;
How to Manage the Relugolix and Lumefantrine Interaction
Both medicines are important, so the usual approach is to keep taking them as prescribed while your care team keeps a closer eye on you.
- Tell your prescriber and pharmacist you take both drugs so they can weigh the benefits of your cancer therapy against the risks.
- Your team may check your electrolytes (like potassium and magnesium) and correct any imbalances, and may do periodic ECGs to watch your heart rhythm.
- They may also watch to make sure the malaria treatment is actually working, since its effect could be weakened.
- Report symptoms like fainting, palpitations, dizziness, or a returning fever right away.
Management is individual — confirm any change with your pharmacist or prescriber.
Questions for Your Pharmacist
- Does my dose of Relugolix or Lumefantrine need adjusting while I take them together?
- What symptoms should prompt me to call you or my prescriber right away?
- Does the timing of my doses matter for this combination?
- Is there another option that avoids this interaction?
Relugolix and Lumefantrine: Common Questions
How serious is the Relugolix and Lumefantrine interaction?
It is rated major. Potentially serious — often needs a change or close monitoring.
How is the Relugolix and Lumefantrine interaction managed?
Both medicines are important, so the usual approach is to keep taking them as prescribed while your care team keeps a closer eye on you. Tell your prescriber and pharmacist you take both drugs so they can weigh the benefits of your cancer therapy against the risks. Your team may check your electrolytes (like potassium and magnesium) and correct any imbalances, and may do periodic ECGs to watch you… Management is individual — always follow your own care team's guidance.
How quickly could this interaction happen?
The documented onset is "unspecified". The timing of this interaction is not well characterized.
How strong is the evidence for this interaction?
The evidence is graded "theoretical". Expected from how the drugs work, or from studies of similar drugs; this exact pair has little direct study.
Ask About the Relugolix and Lumefantrine Interaction
Ask in your own words about taking Relugolix and Lumefantrine together. The answer comes from this page’s interaction record and both drugs’ own information.
This box answers questions about this one combination only. For anything else about either drug, open its drug information page or ask a pharmacist.
AI answers from this page’s record and both drugs’ information, never the open internet. AI can make mistakes, so always check with your doctor or pharmacist.
References (2)
- Product Information: ORGOVYX oral tablets, relugolix oral tablets. Sumitomo Pharma America, Inc (per FDA), Marlborough, MA, 2025. DailyMed
- Product Information: COARTEM® oral tablets, artemether lumefantrine oral tablets. Novartis Pharmaceuticals Corporation (per DailyMed), East Hanover, NJ, 2025. DailyMed
Other Serious Interactions of Relugolix and Lumefantrine
Also serious with Lumefantrine
- CarbamazepineContraindicated
- DronedaroneContraindicated
- FluconazoleContraindicated
- Fluconazole InjectionContraindicated
Also serious with Relugolix
These Medications Also Interact With Supplements
Prescription drugs aren't the whole picture — herbal and dietary supplements can interact with them too. From the evidence-graded Natural Medicines database:
With Relugolix
- GrapefruitMajor
- St. John's WortMajor
- Activated CharcoalMajor
- American HelleboreMajor
- ArsenicMajor
- CesiumMajor
- EphedraMajor
- Sida CordifoliaMajor
- + 149 more
Check everything you take with our drug–supplement interaction checker.
Still Have Questions About This Combination?
Every question gets a real answer from a licensed pharmacist — free, as soon as they can.
About This Library
Built in-house, documented one interaction at a time. Our interaction database is not a complete list of every known interaction: a combination that isn't listed here hasn't been documented by us yet, which never means it's safe. Checking everything you take at once? Ask your pharmacist to review your full medication list. How we build and review it →
What Each Rating Means
Severity Levels
- Contraindicated These should generally not be used together.
- Major Potentially serious — often needs a change or close monitoring. This interaction.
- Moderate Can be significant — usually manageable with monitoring.
- Minor Usually limited clinical impact.
Evidence Grades
- EstablishedWell documented — supported by controlled studies or strong clinical data.
- ProbableGood supporting evidence, though not definitively proven.
- SuspectedSome evidence suggests this interaction, but it is not well established.
- PossibleLimited or conflicting evidence; the interaction may occur.
- TheoreticalExpected from how the drugs work, or from studies of similar drugs; this exact pair has little direct study. This interaction.
How Soon It Shows
- RapidEffects can appear quickly, often within about 24 hours of combining the drugs.
- DelayedEffects tend to build up gradually over days to weeks.
- UnspecifiedThe timing of this interaction is not well characterized. This interaction.
Ratings come from the documented interaction literature and are reviewed by a pharmacist. They describe the documented risk of the combination, not what will necessarily happen to you — your dose, timing, and health picture all matter.